$CING
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
Healthcare
Sector
Biotechnology
Industry
Shane J. Schaffer
CEO
13
Employees
$8.69
Current Price
$32.63M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 4 | 4 | $166,692.96 | 33,074 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 4 | 4 | $166,692.96 | 33,074 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Callahan Jennifer L. SVP and CFO | Purchase | 4,864 | $5.04 | $24,514.56 | View Details |
| Feb 6, 2026 | Werth Peter J. Director | Purchase | 19,455 | $5.04 | $98,053.20 | View Details |
| Feb 6, 2026 | Brams Matthew EVP and Chief Medical Officer | Purchase | 1,946 | $5.04 | $9,807.84 | View Details |
| Feb 6, 2026 | Schaffer Shane J. Director | Purchase | 6,809 | $5.04 | $34,317.36 | View Details |
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.56
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals